ASTRO recommends shorter radiation therapy courses for localized prostate cancer

The American Society for Radiation Oncology (ASTRO) has updated its clinical guidelines to recommend shorter radiation therapy courses for patients with localized prostate cancer. Supported by large clinical trials, the new guidelines endorse moderately shortened treatment schedules and establish five-treatment stereotactic body radiation therapy (SBRT) as a standard option for many patients. This approach aims to maintain cancer control while reducing the number of treatment visits.

Originally published by gnews